CLINICAL TRIAL IN INDIA: RISE AND FALL

Journal Title: International Journal of Drug Regulatory Affairs - Year 2015, Vol 3, Issue 1

Abstract

Fight with the disease is the ever evolving frontier for human beings. Discovery of new drugs and devices through clinical research are the armory to help in the fight with the affliction of mankind. Clinical trials, test potential treatments in human volunteers to see whether they should be approved for wider use in the general population. A treatment could be a drug, medical device, or biologic, such as a vaccine, blood product, or gene therapy. India stood as a global hub for clinical trials in past years. Later, the amendments made in Indian regulations paved for the decline of clinical trials. The aim of this article is to provide the details about the Indian clinical trial application filing process, the amendments made in its regulations and the challenges faced by Indian clinical trial industry.

Authors and Affiliations

Chitral Kulshreshtha, Venkatesh M P, Shrisha K, Pramod Kumar T M

Keywords

Related Articles

MARKETING AUTHORIZATION APPLICATION (MAA) FOR EUROPE MARKET

This article states requirement of Marketing Authorization Application to get registration of Drug Product to EEA. The procedures for application of marketing authorization are: Centralised procedure, National procedure,...

PHARMACOVIGILANCE IN CLINICAL RESEARCH: PAST, PRESENT AND FUTURE

The growing clinical research after the product patents rights for the pharmaceutical industries as per the trade related aspects of intellectual property rights agreement and adverse drug reaction monitoring of the mark...

Integrating PLCM strategy in Pharmaceutical Emerging Market

All products and services must denote definite life cycles. The life cycle talks about the period from the product‘s first launch till it wind-up onto the market. Throughout this age noteworthy modifications are made in...

DRUG REGULATION IN INDIA: SWOT ANALYSIS

Drug regulation plays pivotal role in any country because the purpose of drug regulation is to promote and to protect public health by ensuring the safety, efficacy and quality of drugs. Drug regulation should cover all...

DEVELOPMENT AND VALIDATION OF HPTLC METHOD FOR ESTIMATION OF LEFLUNOMIDE IN ITS PHARMACEUTICAL DOSAGE FORM

A specific, accurate, precise and robust HPTLC method has been developed for estimation of Leflunomide in its pharmaceutical dosage form. The chromatographic separation was performed using Aluminum backed precoated with...

Download PDF file
  • EP ID EP338314
  • DOI -
  • Views 92
  • Downloads 0

How To Cite

Chitral Kulshreshtha, Venkatesh M P, Shrisha K, Pramod Kumar T M (2015). CLINICAL TRIAL IN INDIA: RISE AND FALL. International Journal of Drug Regulatory Affairs, 3(1), 1-13. https://europub.co.uk/articles/-A-338314